Scram News
Deals

Anduril IPO warning points to a fragile listing market

Anduril IPO warning highlights how a reopened U.S. listing market is still being priced on scarcity, strategic-tech hype and timing risk.

By Naomi Voss6 min read
Analyst at a multi-screen trading desk, illustrating the public-market scrutiny that awaits an IPO.

On Thursday, Anduril chief executive Brian Schimpf said it would be a mistake to float the company in the middle of a hype cycle, a conspicuously cool message from a private group that reached a $61 billion valuation in May.

That remark matters beyond one issuer. The U.S. IPO market is being reopened by a small club of private names that investors increasingly treat as scarcity assets: SpaceX, OpenAI and Anthropic sit at the centre of that queue. If one of the hottest issuers is warning about timing rather than celebrating valuation, the cleaner read is that the window is open but still fragile.

But the same setup looks different from the analyst seat. A market with only a few marquee listings can mistake shortage for depth, especially when defense and AI groups are priced as strategic infrastructure as much as businesses. The first weak debut in that club would do more than hurt one ticker. It would test whether the reopening has real public-market demand behind it.

Schimpf’s own test of readiness is more conservative than the tape. He told CNBC that a successful IPO is not the highest first-day print, but whether investors still have a good return three years later. That partially answers the insider’s question hanging over 2026: waiting is not hesitation if the extra time lets revenue, margins and expectations meet in a less promotional market.

A bad time to do that is in the middle of a hype cycle. So we’re not in a rush to go out.
— Brian Schimpf, CNBC

What restraint says about the window

Anduril can afford to be patient. CNBC reported that the May round brought in $5 billion and doubled the company’s valuation to $61 billion, while the Financial Times said the group generated $2.2 billion of revenue in 2025 and is projecting more than $4.3 billion in 2026. Those are large numbers by venture standards. They are also exactly the kind of numbers that tempt founders and bankers to test the market before the income statement catches up with the narrative.

Analyst at a multi-screen trading desk, illustrating the public-market scrutiny that awaits an IPO.

By framing the decision around post-IPO returns instead of the private mark, Schimpf is pointing to a different milestone. The public market does not need another company that can command a premium in a tightly held round. It needs one that can trade through quarterly disclosures, wider ownership and a slower information cycle without forcing buyers to defend the valuation from day one.

That is the insider perspective in plain form. A late private round can absorb ambition because existing investors choose the terms. A listed stock has to clear a broader test every day. For issuers that are still being valued on future strategic relevance, rather than current earnings power, timing discipline may matter more than getting to the bell first.

Why strategic-tech comps matter

The analyst case for caution starts with how narrow the comparison set has become. In CNBC’s June analysis of SpaceX, the company was described less as a conventional aerospace listing than as private geopolitical infrastructure. The same framing has bled into defense tech and frontier AI: the market is paying not only for growth, but for perceived national importance, supply-chain leverage and the fear of missing the few names big enough to anchor a cycle.

Digital stock board showing shifting market prices, reflecting how strategic-tech valuations are compared in real time.

That logic can lift prices quickly, but it can also distort what the market is actually measuring. OpenAI’s planned confidential filing and Anthropic’s $965 billion post-money valuation have given investors giant reference points before they have the discipline of live public trading. When a handful of issuers do all the signalling, scarcity can start to look like price discovery.

Speaking again to CNBC, Schimpf put the problem bluntly:

We’re seeing crazy high valuations on the expectations of future growth.
— Brian Schimpf, CNBC

That line is more useful as market commentary than as founder modesty. It answers, at least in part, the analyst’s question about what is driving the rebound. The current window looks less like a broad reopening of U.S. equity issuance than a selective bid for strategic-tech stories that can be narrated as long-duration winners before public investors have a full earnings record to test.

None of this means the window is closed. It means the window is expensive. The companies most likely to use it are the ones with enough private capital to choose between another round and a float. That paradox matters: the better the issuer, the less urgent the IPO, which leaves public investors competing hardest for the names least willing to rush.

What could reset sentiment

The skeptic’s concern is not that Anduril lacks scale. It is that the entire reopening is being benchmarked against too few companies. CNBC reported in June that California is already counting on a tax windfall from potential listings by SpaceX, OpenAI and Anthropic, a reminder that state budgets, private investors and rival issuers are all leaning on the same shortlist. Concentration like that can flatter sentiment on the way up and magnify disappointment on the way down.

One weak aftermarket performance would not need to be catastrophic to matter. It would only need to show that strategic importance does not exempt a business from ordinary public-market questions about revenue durability, margins and how much growth is already in the price. Anduril at least has a visible operating base in the FT’s reporting, with 2025 revenue of $2.2 billion and a 2026 projection above $4.3 billion. For the broader queue of would-be issuers, the numbers are often thinner than the excitement around them.

Schimpf’s longer-dated standard is the right one to watch.

We define a successful IPO as our investors got a good return three years from actually going out.
— Brian Schimpf, CNBC

That is not how late-cycle windows are usually sold. Bankers prefer momentum, venture investors prefer marks and media cycles prefer the next filing. But if the hottest private groups still think a hype-driven debut is the wrong trade, the market is being told something plain: the U.S. listing window has reopened, yet it is still pricing heat more confidently than it is pricing durability.

AndurilAnthropicBrian SchimpfCaliforniaOpenAIPalmer LuckeySpaceX

Naomi Voss

Banks and deals reporter covering bank earnings, fintech, M&A and IPOs. Reports from New York.

Related